NCT03899467 2024-02-12
The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Completed
Clinical Trials
5 trialsNCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed
NCT05076851 2021-10-13
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT04103853 2021-09-24
Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
Suzhou Kintor Pharmaceutical Inc,
Phase 1 Completed
NCT02826772 2020-03-17
Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer
Suzhou Kintor Pharmaceutical Inc,
Phase 1 Completed